DRUG DESCRIPTION. LEVEMIRÂ® (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as a subcutaneous injection. Insulin detemir is a long-acting (up to 24-hour duration of action) recombinant human insulin analog. LEVEMIRÂ® is produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification.
The UV Index is a linear scale, with higher values representing a greater risk of sunburn (which is correlated with other health risks) due to UV exposure. An index of 0 corresponds to zero UV radiation, as is essentially the case at night.
Ultraviolet (UV) light is light with higher frequency (lower wavelength) than visible light. UV light has frequencies ranging from 8*1014 to 3*1016 Hz (800 THz to 30 PHz) and wavelengths from 10-8 m to 3.8*10-7 m (10 nm to 380 nm). Prolonged exposure to UV light causes sunburn and can cause skin cancer.